Navigate
X
    QualityStocks
  • 18 years ago

Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE)

Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE) is focused on developing therapeutic and diagnostic products designed mainly for disorders in the central nervous system. The company’s robust molecular imaging development program targets the diagnosis of Parkinson’s disease and potentially dementia. Altropane, the company’s lead molecular imaging product candidate, is currently in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes, including Parkinson’s Disease. For further information, visit the Company’s web site at www.alseres.com.

Tags Rodman & Renshaw
Related Post
  1. Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

    In the United States alone, close to one million people are living with MS, with…

  2. Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step

    California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…

  3. Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership

    The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…